HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacques Vignon Selected Research

gacyclidine (GK 11)

1/2013Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11.
5/2002Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jacques Vignon Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
07/2007 - 11/2006
1Glioblastoma (Glioblastoma Multiforme)
10/2017
1Inflammation (Inflammations)
01/2013
1Insulinoma
11/2006
1Spinal Cord Injuries (Spinal Cord Injury)
05/2002

Drug/Important Bio-Agent (IBA)

2gacyclidine (GK 11)IBA
01/2013 - 05/2002
2Glucose (Dextrose)FDA LinkGeneric
07/2007 - 11/2006
1Memantine (Namenda)FDA Link
01/2013
1Insulin (Novolin)FDA Link
11/2006
1Pharmaceutical PreparationsIBA
11/2006
1Adenosine Triphosphate (ATP)IBA
11/2006
1Neuroprotective AgentsIBA
05/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
10/2017